OBJECTIVE: To determine whether or not craniosacral therapy alleviates migraine symptoms. METHODS: A cross-over experimental design was used with twenty participants, aged between 20 and 50 years, who suffered from at least two migraine attacks per month. Participants were randomly assigned to two equal-sized groups, A and B. All received six craniosacral treatments over four weeks and the groups answered the "HIT-6" Questionnaire four times; every four weeks (Times 1, 2, 3 and 4). Group A, received treatment after answering the questionnaire the first time, but Group B, answered the questionnaire twice before receiving treatment. RESULTS: Immediately after treatments and one month afterwards there was significant lowering in HIT-6 scorings compared with prior to treatment. There was also significant difference in HIT-6 scorings between Times 1 and 4 (p = 0.004). The effect size was 0.43-0.55. CONCLUSION: The results indicate that craniosacral treatment can alleviate migraine symptoms. Further research is suggested.
RCT Entities:
OBJECTIVE: To determine whether or not craniosacral therapy alleviates migraine symptoms. METHODS: A cross-over experimental design was used with twenty participants, aged between 20 and 50 years, who suffered from at least two migraine attacks per month. Participants were randomly assigned to two equal-sized groups, A and B. All received six craniosacral treatments over four weeks and the groups answered the "HIT-6" Questionnaire four times; every four weeks (Times 1, 2, 3 and 4). Group A, received treatment after answering the questionnaire the first time, but Group B, answered the questionnaire twice before receiving treatment. RESULTS: Immediately after treatments and one month afterwards there was significant lowering in HIT-6 scorings compared with prior to treatment. There was also significant difference in HIT-6 scorings between Times 1 and 4 (p = 0.004). The effect size was 0.43-0.55. CONCLUSION: The results indicate that craniosacral treatment can alleviate migraine symptoms. Further research is suggested.
Authors: Elena Muñoz-Gómez; Marta Inglés; Marta Aguilar-Rodríguez; Sara Mollà-Casanova; Núria Sempere-Rubio; Pilar Serra-Añó; Gemma V Espí-López Journal: J Clin Med Date: 2022-01-30 Impact factor: 4.241
Authors: Elena Muñoz-Gómez; Pilar Serra-Añó; Sara Mollà-Casanova; Núria Sempere-Rubio; Marta Aguilar-Rodríguez; Gemma V Espí-López; Marta Inglés Journal: J Clin Med Date: 2022-08-11 Impact factor: 4.964
Authors: Cesar E Jara Silva; Andrew M Joseph; Mohammed Khatib; Jenna Knafo; Monica Karas; Kristina Krupa; Benjamin Rivera; Alexander Macia; Bhargavi Madhu; Mary McMillan; Jason Burtch; Jonathan Quinonez; Trevine Albert; Deepesh Khanna Journal: Cureus Date: 2022-08-09